ArticleTherapeutic innovation & regulatory science2026
Evaluating Post-Progression Survival in the Context of Progression-Free Survival Benefits: A Revisit of the CodeBreaK200 Design.
Zhoujingpeng Wei et al.PubMed ↗Publisher ↗
No numbers read from the abstract.